Improving cardiovascular risk assessment using ultrasound imaging

使用超声成像改善心血管风险评估

• 批准号: 8081011
• 负责人: VIJAY NAMBI
• 金额: $ 13.65万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8081011
• 关键词: 3-Dimensional; 9p21; Adult; Advisory Committees; Arterial Fatty Streak; Atherosclerosis; Biological Markers; Blood Vessels; Cardiology; Cardiovascular Diseases; Cardiovascular system; Carotid Arteries; Carotid Endarterectomy; Cause of Death; Chromosomes; Clinical; Clinical Research; Communities; Coronary heart disease; Dimensions; Doctor of Medicine; Doctor of Philosophy; Echocardiography; Enrollment; Evaluation; Future; Genotype; Goals; Histology; Image; Imaging technology; Incidence; Individual; Instruction; Intervention; K-Series Research Career Programs; Magnetic Resonance Imaging; Measurement; Measures; Medicine; Mentors; Methods; Patient Schedules; Preventive; Principal Investigator; Public Health; Research; Research Personnel; Risk; Risk Assessment; Risk Factors; Risk Management; Scientist; Single Nucleotide Polymorphism; Stroke; Technology; Texas; Thick; Time; Training; Training Programs; Ultrasonography; Western World; Work; abstracting; base; cardiovascular disorder risk; cardiovascular risk factor; college; heart disease risk; improved; in vivo; intima media; novel; professor; research study

DESCRIPTION (provided by applicant): The candidate, Vijay Nambi, M.D., is a clinician trained in adult cardiology and vascular medicine who is currently an Assistant Professor (tenure track) in the Department of Medicine, Section of Atherosclerosis and Vascular Medicine at Baylor College of Medicine, Houston, Texas. The candidate's long term goal is to become an established independent investigator in the field of atherosclerosis and preventive cardiology. In order to achieve his stated goal, he has enrolled in the clinical scientist training program and is currently working towards a Ph.D. in clinical research with formal mentoring by a Ph.D. advisory committee. The K-23 career development award will provide the candidate with the opportunity to pursue research studies aimed at improving cardiovascular risk prediction using novel biomarkers, genotyping and imaging with a focus on application of new advances in ultrasound imaging technology to improve the evaluation of atherosclerosis with potential future application in cardiovascular risk assessment and management. Although existing methods to evaluate cardiovascular risk such as the Framingham risk scores are good, they fail to identify several individuals who develop cardiovascular disease. Under the guidance of Dr. Ballantyne and an outstanding group of advisors, the candidate proposes the following,specific aims aimed at improving cardiovascular disease risk prediction: 1. Evaluate whether carotid initima media thickness (C-IMT) and presence of plaque can improve cardiovascular (coronary heart disease [CHD] and stroke) risk prediction 2. Evaluate whether the addition of single nucleotide polymorphism (rs1333049) in chromosome 9p21 (known to be associated with CHD) to C-IMT will further improve CHD risk prediction 3. Evaluate whether ex-vivo and in-vivo 3-dimensional ultrasound imaging can reliably estimate atherosclerotic plaque volume and composition when compared to magnetic resonance imaging and histology and 4. Evaluate whether carotid artery stiffness is associated with incident CHD and stroke in the ARIC study and whether carotid artery strain can be reliably measured by adapting novel echocardiography-based technology to carotid ultrasound imaging. RELEVANCE (See instructions): This research is of significant public health importance. The ability to improve cardiovascular disease risk prediction may allow for timely interventions that decrease the incidence of cardiovascular disease, the leading cause of death in the western world. (End of Abstract)

描述（由申请人提供）：候选人Vijay Nambi，医学博士，是一名接受过成人心脏病学和血管医学培训的临床医生，目前是德克萨斯州休斯顿贝勒医学院医学系动脉粥样硬化和血管医学科的助理教授（终身教职）。候选人的长期目标是成为动脉粥样硬化和预防心脏病学领域的独立研究者。为了实现他的既定目标，他参加了临床科学家培训计划，目前正在攻读博士学位。在临床研究中有一位博士的正式指导。咨询委员会。K-23职业发展奖将为候选人提供机会进行研究，旨在使用新型生物标志物，基因分型和成像来改善心血管风险预测，重点是超声成像技术的新进展，以改善动脉粥样硬化的评估，并在心血管风险评估和管理中具有潜在的未来应用。虽然现有的方法来评估心血管疾病的风险，如心脏病风险评分是好的，他们未能确定几个人谁发展心血管疾病。在Ballantyne博士和一群杰出的顾问的指导下，候选人提出了以下旨在改善心血管疾病风险预测的具体目标：1。评估颈动脉内膜中层厚度（C-IMT）和斑块的存在是否可以改善心血管（冠心病[CHD]和中风）风险预测。评估在C-IMT中增加染色体9 p21（已知与CHD相关）的单核苷酸多态性（rs 1333049）是否会进一步改善CHD风险预测3。评价与磁共振成像和组织学相比，体外和体内三维超声成像是否可以可靠地估计动脉粥样硬化斑块的体积和组成。评价ARIC研究中颈动脉僵硬度是否与CHD和卒中事件相关，以及颈动脉应变是否可以通过将基于超声心动图的新技术应用于颈动脉超声成像来可靠地测量。相关性（见说明）：本研究具有重要的公共卫生意义。改善心血管疾病风险预测的能力可能有助于及时采取干预措施，降低心血管疾病的发病率，心血管疾病是西方世界的主要死亡原因。 (End摘要）

项目成果

Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training.

实习医生非高密度脂蛋白胆固醇计算和目标意识。

• DOI: 10.1016/j.jacl.2011.10.020
• 发表时间: 2012
• 期刊: Journal of clinical lipidology
• 影响因子: 4.4
• 作者: Negi,SmitaI;Steinberg,Lynne;Polsani,VenkateshwarR;Gowani,SaqibA;Nambi,Vijay;Kumar,Varinder;Marinescu,Victor;Jones,PeterH;Petersen,LauraA;Ballantyne,ChristieM;Virani,SalimS
• 通讯作者: Virani,SalimS

Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis.

胆固醇酯转移蛋白基因的单核苷酸多态性与动脉粥样硬化患者的复发性冠心病或死亡率。

• DOI: 10.1016/j.amjcard.2013.05.073
• 发表时间: 2013
• 期刊: The American journal of cardiology
• 作者: Virani,SalimS;Lee,Vei-Vei;Brautbar,Ariel;Grove,MeganL;Nambi,Vijay;Alam,Mahboob;Elayda,MacArthur;Wilson,JamesM;Willerson,JamesT;Boerwinkle,Eric;Ballantyne,ChristieM
• 通讯作者: Ballantyne,ChristieM